Portfolio (Quarterly)
Guide ↗
MPM BIOIMPACT LLC
· CIK 0001687078| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | DYN | Dyne Therapeutics, Inc. | Healthcare | 1,408,152.0 | $25.5M | 1.97% | — | — | $18.13 | -4.2% |
| 22 | STOK | Stoke Therapeutics Inc | Healthcare | 767,038.0 | $25.0M | 1.93% | — | — | $32.56 | -6.9% |
| 23 | CRVS | Corvus Pharmaceuticals Inc | Healthcare | 1,674,875.0 | $24.5M | 1.89% | -1.1M | -39.0% | $14.63 | -10.6% |
| 24 | RLAY | Relay Therapeutics Inc. | Healthcare | 2,359,586.0 | $23.5M | 1.81% | +127K | +5.7% | $9.95 | +30.9% |
| 25 | TARS | Tarsus Pharmaceuticals Inc | Healthcare | 329,750.0 | $23.1M | 1.79% | — | — | $70.15 | -7.6% |
| 26 | ORIC | Oric Pharmaceuticals Inc | Healthcare | 1,803,945.0 | $22.9M | 1.76% | — | — | $12.67 | -33.2% |
| 27 | QURE | Uniqure NV | Healthcare | 1,369,231.0 | $22.4M | 1.73% | -12K | -0.9% | $16.35 | +50.5% |
| 28 | GLUE | Monte Rosa Therapeutics Inc | Healthcare | 1,176,928.0 | $19.4M | 1.50% | — | — | $16.45 | +14.8% |
| 29 | NTRA | Natera Inc | Healthcare | 93,074.0 | $18.6M | 1.44% | -477.0 | -0.5% | $199.99 | +1.9% |
| 30 | — | Climb Bio Inc | — | 2,593,439.0 | $17.8M | 1.37% | -78K | -2.9% | $6.85 | — |
| 31 | ARQT | Arcutis Biotherapeutics Inc | Healthcare | 733,966.0 | $17.3M | 1.33% | +203K | +38.2% | $23.56 | -10.8% |
| 32 | URGN | Urogen Pharma Ltd | Healthcare | 943,803.0 | $17.0M | 1.31% | — | — | $17.98 | +68.1% |
| 33 | — | Bright Minds Biosciences Inc | — | 212,175.0 | $15.5M | 1.20% | -18K | -7.8% | $72.97 | — |
| 34 | — | Zymeworks, Inc. | — | 565,249.0 | $14.2M | 1.09% | NEW | — | $25.04 | — |
| 35 | BLTE | Belite Bio Inc | Healthcare | 88,045.0 | $14.0M | 1.08% | — | — | $159.44 | -9.5% |
| 36 | VRDN | Viridian Therapeutics Inc | Healthcare | 649,873.0 | $12.7M | 0.98% | NEW | — | $19.56 | -9.9% |
| 37 | — | enGene Holdings, Inc. | — | 1,845,373.0 | $12.6M | 0.97% | — | — | $6.81 | — |
| 38 | ABVX | Abivax SA | Healthcare | 107,268.0 | $11.9M | 0.92% | +51K | +90.5% | $111.35 | +11.4% |
| 39 | ALLO | Allogene Therapeutics, Inc. | Healthcare | 2,242,933.0 | $5.5M | 0.42% | NEW | — | $2.44 | -19.7% |
| 40 | ACRS | Aclaris Therapeutics Inc | Healthcare | 391,918.0 | $1.5M | 0.11% | NEW | — | $3.75 | +21.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%